Comments
Loading...
Immunic (NASDAQ:IMUX) Stock Quotes, Forecast and News Summary
Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immunic (IMUX) stock?
You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.
Who are Immunic (IMUX) competitors?
Other companies in Immunic’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX) and Skye Bioscience (NASDAQ:SKYE).
What is the forecast, or price target, for Immunic (IMUX) stock?
Immunic has a consensus price target of $15.09.
What is the current price for Immunic (IMUX)?
The stock price for Immunic (NASDAQ: IMUX) is $1.275 last updated February 21, 2025 at 10:09 AM EST.
Does Immunic (IMUX) pay a dividend?
There are no upcoming dividends for Immunic.
When is Immunic (NASDAQ:IMUX) reporting earnings?
Immunic’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Immunic (IMUX) going to split?
There is no upcoming split for Immunic.
What sector and industry does Immunic (IMUX) operate in?
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.